Accesswire
30 Sept 2026, 11:45 UTC · 2h ago
Verdict
Headline takes no side. We score VBIO +0.80 across three claims — strongly bullish.
+0.80strongly bullish
More positive than 89% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish · 3 new · 0 priced in
Valion estimates a successful oral mucosal formulation could increase the potential U.S. dose requirement by 10 to 40 times compared to the injectable program.
Newpress release dated September 30, 2026
So whatThe addressable market would expand to include ~3.8 million personnel (military, fire, police), significantly raising long-term revenue ceilings if authorized.
More positive than 94% of claims this week
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
Valion and Shear Kershman Laboratories have completed the formulation of an oral mucosal version of Entolimod using the BioViscid™ platform.
Newpress release dated September 30, 2026
More positive than 79% of claims this week
The next development milestone is a study to determine if the oral mucosal formulation delivers measurable amounts of Entolimod into the bloodstream.
Newpress release dated September 30, 2026
More positive than 67% of claims this week
Which stocks this story touches
More positive than 89% of ticker scores this week
The company successfully formulated a needle-free oral version of Entolimod, potentially expanding its addressable market by 10 to 40 times.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
24/7 Wall Street
29m ago
+25.8%
Price agrees with the score
$3.56 vs $2.83 close before publication (Sep 29) · not market-adjusted
VBIO chart →
